Macromolecular Crowding Accelerates Amyloid Formation by Human Apolipoprotein C-II*

Human apolipoprotein C-II (apoC-II) slowly forms amyloid fibers in lipid-free solutions at physiological pH and salt concentrations (Hatters, D. M., MacPhee, C. E., Lawrence, L. J., Sawyer, W. H., and Howlett, G. J. (2000)Biochemistry 39, 8276–8283). Measurements of the time dependence of solution turbidity, thioflavin T reactivity, and the amount of sedimentable aggregate reveal that the rate and extent of amyloid formation are significantly increased by the addition of an inert polymer, dextran T10, at concentrations exceeding 20 g/liter. High dextran concentrations do not alter the secondary structure of the protein, fiber morphology, or the thioflavin T and Congo Red binding capacity of apoC-II amyloid. Analytical ultracentrifugation studies show that monomeric apoC-II does not associate significantly with dextran. The observed dependence of the overall rate of amyloid formation on dextran concentration may be accounted for quantitatively by a simple model for nonspecific volume exclusion. The model predicts that an increase in the fractional volume occupancy of macromolecules in a physiological fluid can nonspecifically accelerate the formation of amyloid fibers by any amyloidogenic protein.

[1]  K. Sletten,et al.  Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. , 1995, The American journal of pathology.

[2]  R. Jackson,et al.  Isolation and properties of human apolipoproteins C-I, C-II, and C-III. , 1986, Methods in enzymology.

[3]  R. Havel,et al.  Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources. , 1973, Biochemistry.

[4]  C. MacPhee,et al.  Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops. , 2000, Biochemistry.

[5]  G. Howlett,et al.  Sub‐micellar phospholipid accelerates amyloid formation by apolipoprotein C‐II , 2001, FEBS letters.

[6]  G. Howlett,et al.  NMR structure of human apolipoprotein C-II in the presence of sodium dodecyl sulfate. , 2001, Biochemistry.

[7]  S. Zimmerman,et al.  Macromolecular crowding effects on macromolecular interactions: some implications for genome structure and function. , 1993, Biochimica et biophysica acta.

[8]  C. MacPhee,et al.  Determination of sedimentation coefficients for small peptides. , 1998, Biophysical journal.

[9]  R. Ellis,et al.  Macromolecular crowding: an important but neglected aspect of the intracellular environment. , 2001 .

[10]  Allen P. Minton,et al.  The effect of volume occupancy upon the thermodynamic activity of proteins: some biochemical consequences , 2004, Molecular and Cellular Biochemistry.

[11]  A. Minton,et al.  Macromolecular crowding: biochemical, biophysical, and physiological consequences. , 1993, Annual review of biophysics and biomolecular structure.

[12]  S. Udenfriend,et al.  Fluorometric assay of proteins in the nanogram range. , 1973, Archives of biochemistry and biophysics.

[13]  Christopher M. Dobson,et al.  Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.

[14]  F. Ferrone,et al.  Analysis of protein aggregation kinetics. , 1999, Methods in enzymology.

[15]  T. Wisniewski,et al.  Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. , 1995, The American journal of pathology.

[16]  M. Eulitz,et al.  Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis. , 2001, Biochemical and biophysical research communications.

[17]  C. S. Wang,et al.  Isolation and characterization of recombinant human apolipoprotein C-II expressed in Escherichia coli. , 1996, Biochimica et biophysica acta.

[18]  I. Nagy,et al.  Protein and water contents of aging brain. , 1982, Experimental brain research.

[19]  H. Levine,et al.  Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.

[20]  Christopher M. Dobson,et al.  Amyloid fibrils from muscle myoglobin , 2001, Nature.

[21]  C. Dobson Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[22]  M. Lalowski,et al.  Is Alzheimer's disease an apolipoprotein E amyloidosis? , 1995, The Lancet.

[23]  H. Levine Quantification of beta-sheet amyloid fibril structures with thioflavin T. , 1999, Methods in enzymology.

[24]  T. Laurent,et al.  A theory of gel filtration and its exeperimental verification , 1964 .

[25]  S. Yokoyama,et al.  Behavior of apolipoprotein C-II in an aqueous solution. , 1982, Journal of biochemistry.

[26]  Charles Tanford,et al.  Physical Chemistry of Macromolecules , 1961 .

[27]  G. Rivas,et al.  Direct observation of the self-association of dilute proteins in the presence of inert macromolecules at high concentration via tracer sedimentation equilibrium: theory, experiment, and biological significance. , 1999, Biochemistry.

[28]  J. Kelly,et al.  Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.

[29]  A. Minton Implications of macromolecular crowding for protein assembly. , 2000, Current opinion in structural biology.

[30]  J. Calvin Giddings,et al.  Statistical theory for the equilibrium distribution of rigid molecules in inert porous networks. Exclusion chromatography , 1968 .

[31]  A. G. Ogston,et al.  The spaces in a uniform random suspension of fibres , 1958 .

[32]  D. Naber,et al.  Content of water-soluble and total proteins in the aging human brain , 1979, Experimental Gerontology.

[33]  W. Klunk,et al.  Quantifying amyloid by congo red spectral shift assay. , 1999, Methods in enzymology.

[34]  A. Minton,et al.  Molecular crowding: analysis of effects of high concentrations of inert cosolutes on biochemical equilibria and rates in terms of volume exclusion. , 1998, Methods in enzymology.

[35]  B. J. Barber,et al.  Age-related changes in rat interstitial matrix hydration and serum proteins. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.

[36]  G. Marhaug,et al.  Transformation of Amyloid Precursor SAA to Protein AA and Incorporation in Amyloid Fibrils in Vivo , 1985, Scandinavian journal of immunology.

[37]  G. Irvine,et al.  Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins. , 2000, Journal of structural biology.

[38]  A. Minton,et al.  Effects of excluded surface area and adsorbate clustering on surface adsorption of proteins. II. Kinetic models. , 2001, Biophysical journal.

[39]  J. Liepnieks,et al.  A new human hereditary amyloidosis: the result of a stop-codon mutation in the apolipoprotein AII gene. , 2001, Genomics.

[40]  J. Carver,et al.  The Molecular Chaperone, α-Crystallin, Inhibits Amyloid Formation by Apolipoprotein C-II* , 2001, The Journal of Biological Chemistry.

[41]  C. Dobson,et al.  Protein subunit interactions and structural integrity of amyloidogenic transthyretins: evidence from electrospray mass spectrometry. , 1998, Journal of molecular biology.

[42]  A. Minton,et al.  The Influence of Macromolecular Crowding and Macromolecular Confinement on Biochemical Reactions in Physiological Media* , 2001, The Journal of Biological Chemistry.

[43]  P. Lansbury Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Schuck,et al.  Determination of the sedimentation coefficient distribution by least-squares boundary modeling. , 2000, Biopolymers.

[45]  K. Kitagawa,et al.  Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis. , 1991, The Biochemical journal.

[46]  I. Zs.-Nagy,et al.  Alterations in total content and solubility characteristics of proteins in rat brain and liver during ageing and centrophenoxine treatment , 1981, Experimental Gerontology.